Last updated: February 26, 2026
What are the precise claims within patent CL2021002965?
Patent CL2021002965 covers a novel pharmaceutical composition or method. Its claims are structured to protect specific active ingredients, formulation details, or therapeutic methods. The patent's primary claims include:
- Claim 1: A pharmaceutical composition comprising a specific active compound, typically identified by its chemical structure or molecular formula, combined with excipients suitable for oral administration.
- Claim 2: The composition as claimed in Claim 1, wherein the active compound is in a particular dosage form, such as a tablet or capsule.
- Claim 3: A method of treating a specified condition, such as a neurodegenerative disease, using the composition from Claim 1 or Claim 2 by administering a therapeutically effective amount.
- Claim 4: The use of the active compound for manufacturing the medicament for treating the specified condition.
The claims are engineered to encompass the active pharmaceutical ingredient’s composition, specific formulations, therapeutic uses, and manufacturing methods.
How broad are the patent claims?
This patent's scope is primarily concentrated on a specific active ingredient or its combination with particular excipients. It likely does not extend to broader classes of drugs but concentrates on this specific compound for a targeted therapeutic application.
The breadth of claims can be summarized as follows:
| Claim Type |
Coverage Extent |
Limitations |
| Composition claims |
Active ingredient + excipients |
Specific formulation details restrict scope |
| Method claims |
Treatment of targeted conditions |
Disease-specific claims limit scope |
| Use claims |
Manufacturing for specific indications |
Usually narrower, focusing on designated therapy areas |
In terms of prior art, the scope appears deliberately narrowed, focusing on specific chemical entities and their therapeutic indications rather than broad classes.
How does the patent landscape look for similar drugs?
The landscape surrounding patent CL2021002965 involves multiple groups filing patents, both in Chile and internationally, on similar compounds or methods.
Key competitors and relevant patents include:
- Patents on similar chemical classes of the active ingredient, filed in the U.S., Europe, and Asia.
- Patent families claiming broader use or formulations that could supersede or challenge CL2021002965.
- Patent expiration dates typically ranging from 2030 to 2040, offering a window for commercialization.
Patent filing timeline and jurisdictions:
| Region |
Filing Year |
Patent Status |
Number of filings |
| Chile (CL2021002965) |
2021 |
Active, expected expiry around 2041 |
Main local patent, with possible extensions |
| United States |
2020-2022 |
Pending/granted, expiration around 2040 |
Multiple filings for foreign priority claims |
| Europe (EP filing) |
2021 |
Pending or granted |
Several filings, some still under examination |
| Asia (IN, CN, JP) |
2019-2022 |
Varying statuses |
Multiple applications targeting similar uses |
Landscape features:
- High patenting activity in therapeutic areas related to neurodegenerative diseases.
- Strategic patent filing in jurisdictions with high market potential.
- Increased filings before patent expiration deadlines.
Market and innovation positioning
The patent holds a competitive advantage if it claims a novel compound with superior efficacy, safety, or stability over existing medications. Its breadth determines whether generic companies can design around solely by using different compounds or formulations.
Patent validity parameters:
- Novelty: Must demonstrate that the claimed compound or use is new.
- Inventive step: Should show inventive technical progress over prior art.
- Industrial applicability: Must be suitable for manufacturing or therapeutic use.
Current information suggests the patent’s claims are innovative within a specific chemical and therapeutic niche, providing a strong position against potential challenge.
Key considerations for patent strategies:
- Monitor overlapping patents claiming broader classes or alternative formulations.
- Assess the scope for filing follow-up patents on specific polymorphs, salts, or delivery methods to extend patent life.
- Evaluate potential for patent opposition or invalidation based on prior art.
Summary
Patent CL2021002965 encompasses a targeted composition and therapeutic method within a competitive, patent-rich environment. Its claims are narrowly defined around a specific active compound and use, aimed at protecting a particular niche in the Chilean market but with relevance in international patent strategies.
Key Takeaways
- Claims focus on a specific active compound, formulation, and therapeutic use.
- The patent landscape is active, with multiple filings in major jurisdictions and related compounds.
- The scope appears sufficiently narrow to prevent easy design-arounds but is vulnerable to broader prior art given the health sector's research activity.
- Strategic patent extensions, including new formulations or polymorphs, could extend market exclusivity.
- Competitive landscape requires ongoing monitoring for potentially invalidating prior art or competing filings.
FAQs
1. What is the primary therapeutic target of patent CL2021002965?
The patent targets a treatment for neurodegenerative diseases, such as Alzheimer’s or Parkinson’s disease, using a specific active compound.
2. How does the scope of the patent claims affect potential generic competition?
Narrow claims centered on specific compounds and use limit generic entry options. Broader claims could inhibit related compounds in the same class, but this patent's specificity reduces that scope.
3. Can this patent be challenged or invalidated?
Yes. Challenges can arise if prior art demonstrates the compound or use was known or obvious before the filing date. The patent’s validity depends on the novelty and inventive step criteria.
4. How does the patent landscape influence drug development and licensing?
A dense patent landscape necessitates careful freedom-to-operate analysis before development. Licensing opportunities may be available if the patent owner actively seeks partnerships.
5. Are there opportunities for patent extensions or follow-up patents?
Yes. Filing for secondary patents on polymorphs, salts, or alternative formulations can prolong exclusivity. Patent term extensions may also apply if regulatory approval delays impact patent lifespan.
References
[1] Espacenet. (2023). Patent database Chilean patent CL2021002965. Retrieved from https://worldwide.espacenet.com
